Valley Wealth Managers Inc. Grows Stake in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Valley Wealth Managers Inc. lifted its stake in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 200.0% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 900 shares of the company’s stock after purchasing an additional 600 shares during the period. Valley Wealth Managers Inc.’s holdings in iShares U.S. Pharmaceuticals ETF were worth $61,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of IHE. National Bank of Canada FI grew its stake in iShares U.S. Pharmaceuticals ETF by 274.0% during the 4th quarter. National Bank of Canada FI now owns 187 shares of the company’s stock valued at $35,000 after acquiring an additional 137 shares in the last quarter. Global Retirement Partners LLC grew its stake in iShares U.S. Pharmaceuticals ETF by 454.1% during the 1st quarter. Global Retirement Partners LLC now owns 410 shares of the company’s stock valued at $28,000 after acquiring an additional 336 shares in the last quarter. Y.D. More Investments Ltd grew its stake in iShares U.S. Pharmaceuticals ETF by 29.0% during the 4th quarter. Y.D. More Investments Ltd now owns 516 shares of the company’s stock valued at $96,000 after acquiring an additional 116 shares in the last quarter. Concourse Financial Group Securities Inc. boosted its holdings in iShares U.S. Pharmaceuticals ETF by 331.0% in the 1st quarter. Concourse Financial Group Securities Inc. now owns 543 shares of the company’s stock valued at $37,000 after purchasing an additional 417 shares during the last quarter. Finally, Trust Co. of Vermont acquired a new position in iShares U.S. Pharmaceuticals ETF in the 3rd quarter valued at about $107,000.

iShares U.S. Pharmaceuticals ETF Stock Up 1.0 %

NYSEARCA:IHE traded up $0.67 on Thursday, hitting $68.16. The stock had a trading volume of 50,578 shares, compared to its average volume of 72,088. The stock has a market cap of $688.42 million, a price-to-earnings ratio of 6.49 and a beta of 0.58. The company has a fifty day moving average price of $66.11 and a two-hundred day moving average price of $65.68. iShares U.S. Pharmaceuticals ETF has a 1-year low of $55.36 and a 1-year high of $69.56.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.